Pfizer Inc 2007 SR
The report details Pfizer's corporate responsibility performance for 2006 and strategic initiatives for 2007. Key highlights include the submission of 19 new medicines for FDA approval and the launch of breakthrough treatments for HIV/AIDS and cancer. The company demonstrated significant environmental progress, reducing greenhouse gas emissions by 32.7% relative to sales since 2000 and meeting volatile organic compound reduction targets two years early. Pfizer also expanded its commitment to global health through the Mobilize Against Malaria program and enhanced clinical trial transparency by registering all patient studies on public databases.
Company: Pfizer Inc
Sector: Health Care
Country: United States
Year: 2007
Type: SR
Pages: 122
Pfizer Inc
Corporate Responsibility Report
The report details Pfizer's corporate responsibility performance for 2006 and strategic initiatives for 2007. Key highlights include the submission of 19 new medicines for FDA approval and the launch of breakthrough treatments for HIV/AIDS and cancer. The company demonstrated significant environmental progress, reducing greenhouse gas emissions by 32.7% relative to sales since 2000 and meeting volatile organic compound reduction targets two years early. Pfizer also expanded its commitment to global health through the Mobilize Against Malaria program and enhanced clinical trial transparency by registering all patient studies on public databases.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2007
Reporting Period
Jan 1, 2006 - Dec 31, 2006
Fiscal Year
2006
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Renewable Energy
Water Consumption
Total Waste
Employees